Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:4/14/2009

ars following surgery. The U.S. Food and Drug Administration (FDA) has given the go-ahead for a Phase III clinical trial with Multikine and granted orphan drug status to Multikine in the neoadjuvant therapy of squamous cell carcinoma (cancer) of the head and neck. Most recently CEL-SCI completed construction of the manufacturing facility to produce Multikine for the Phase III trial and subsequent sale following approval.

Multikine, a patented defined mixture of naturally derived cytokines, is the first immunotherapeutic agent in a new class of drugs called "Immune SIMULATORS". Immune SIMULATORS simulate the way our natural immune system acts in defending us against cancer. As opposed to other immunotherapies which are designed to target a single or limited number of specific antigens or molecules, Immune SIMULATORS are multi-targeted; they simultaneously cause a direct and targeted killing of the specific tumor cells and they activate the immune system to produce a stronger anti-tumor attack on multiple fronts.

Multikine is also the first immunotherapeutic agent being developed as a first-line standard of care treatment for cancer. It is administered prior to any other cancer therapy because that is the period when the anti-tumor immune response can still be fully activated. Once the patient has advanced disease, or had surgery or has received radiation and/or chemotherapy, the immune system is severely weakened and is less able to mount an effective anti-tumor immune response. Other immunotherapies are administered after the patient has received chemotherapy and/or radiation therapy, which can limit their effectiveness.

The Company has operations in Vienna, Virginia and Baltimore, Maryland. CEL-SCI's other products, which are currently in pre-clinical stage, have shown protection against a number of diseases in animal tests and are being tested against diseases associated with bio-defense. Another product,
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
2. CEL-SCI Corporation Releases Letter to Shareholders
3. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
4. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
5. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
6. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI Corporation Announces 2007 Financial Results
9. CEL-SCI Corporation Reports First Quarter Financial Results
10. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
11. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Northstar ... announced that after months of hard work from ... the new Snorenz formulation and package design.  The ... and B-6 back into the product due to ... longer lasting effects.  Snorenz Nighttime will also include ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine ... methamphetamine offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... a Minnesota-based medical device company, has announced that they have ... F acilitated A ntegrade S teering T ... cclusions (PFAST-CTOs) study.  The company received approval from the FDA ... IDE for the peripheral devices and is now actively enrolling ...
... In a letter to Congressional Leadership, the Biotechnology ... Congress to support the U.S. Food and Drug Administration,s ... During House consideration of H.R. 2112, the ... Administration, and Related Agencies Appropriations Act, an amendment was ...
Cached Medicine Technology:BridgePoint Medical Announces US IDE Approval and First Patient Enrollment of Peripheral Chronic Total Occlusion Study 2Hill Leadership: Support Science-Based Assessments by FDA 2
(Date:8/22/2014)... Teen substance abuse has long been ... most young adults never receive the professional treatment they ... the new Troubled Teens Columbus helpline was established to ... their drug and alcohol dependencies . , ... their parents can speak directly to a representative who ...
(Date:8/22/2014)... Hills, CA (PRWEB) August 22, 2014 Dr ... Personal for this snoring cure. , In the October 2014 ... interview of Dr Grossan about his method of treating snoring, ... article quotes Dr Grossan: "Nearly half of all adults snore ... sleeping. This is because air passages in the back ...
(Date:8/21/2014)... 2014 Benefiting from accelerated aging ... expenses, the Chinese orthopedic instrument market demand has ... CAGR of 19.2% during 2009-2013. Trauma products, spine ... of orthopedic instruments in China, of which trauma ... in 2013. , Being optimistic about bright future ...
(Date:8/21/2014)... 2014 Strongly influenced by their ... when there are no consequences, researchers in Georgia ... , This could imply that humans are less ... others, researchers said. Their findings are published in ... sense of unfairness is affected by their self-interest, ...
(Date:8/21/2014)... 21, 2014 Local agencies in the ... discounts for specific protection plans, according to released insurer ... to quote life insurance from local agencies using its ... agents that appear inside of the national system are ... of price reviews this year. Adults who enter the ...
Breaking Medicine News(10 mins):Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 3Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 2Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 3Health News:Life Insurance from Local Agents Now Priced Nationally Through Complimentary Tool Online 2
... your hair and nails don,t grow after death, report says , , ... your mind is the idea that you should drink at least ... may have nodded in agreement when someone mentioned scientific studies showing ... , And you may have lectured your children about the danger ...
... 20 Percent of Cost for New Hospital, SAN ... has reached its $50 million Capital Campaign,goal, the largest ... recent gift of $500,000 from the Stephen and Mary ... http://www.newscom.com/cgi-bin/prnh/20071220/DC10448 ), "It,s only fitting that ...
... ALEXANDRIA, Va., Dec. 20 New research,published in ... high risk,overweight adolescents, ages 10-15, can lose weight ... for other less healthy snack choices. The,study, "Weight ... Trial" describes the "Family Lifestyle and Overweight" (FLOW),Prevention ...
... Inc. (Amex: IMA ) a leading manufacturer ... and professional markets, today,announced that it will acquire ... a privately held drugs of abuse diagnostics and,testing ... Santa,Rosa, California primarily distributes rapid drugs of abuse ...
... Capital,Corporation (Nasdaq: MCGC ) today announced a second ... of Gould & Lamb, LLC by ABRY,Partners LLC., ... is unique to,the workers, compensation industry. The company has ... industry,since 2001. Having completed in excess of 40,000 MSAs, ...
... Hospitals are dangerous,places and the danger is even ... bone, temps are relied on more than usual, and ... Betsy McCaughey, Ph.D., Chairman of the Committee to Reduce ... the,country that hospital staff are eager to improve your ...
Cached Medicine News:Health News:Busting Medical Myths Even Doctors Believe 2Health News:Sharp HealthCare Foundation Reaches $50 Million Goal 2Health News:Sharp HealthCare Foundation Reaches $50 Million Goal 3Health News:Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study 2Health News:Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study 3Health News:Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory 2Health News:Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory 3Health News:MCG Capital Invests in Gould & Lamb 2Health News:How to Survive an Unexpected Trip to the Hospital During Christmas and New Years 2
EchoScan US-2500 is available in a single configuration or in combination with the A scan for maximum cost efficiency....
EchoScan US-3300 takes accurate axial length and corneal thickness measurements in either automatic or manual modes. It is available in a single configuration or in combination with the A scan for ma...
PremierEdge Stab Knives - 45....
... The Answer to Micro-Incision ... Technology With its unique ... microsurgical knife is ideal for ... creates reproducible incisions that allow ...
Medicine Products: